03
Dec
2025
18:00
ET
Webinar
Renal Denervation in 2025: What the Latest Data and Guidelines Mean for Your Practice
00
Days
00
Hours
00
Mins
00
Secs
Faculty:
Sripal Bangalore
Ajay J Kirtane
Luke Laffin
Behnam Tehrani
Overview
Renal denervation (RDN) continues to evolve as an evidence-based intervention in the management of hypertension, supported by recent updates to international guidelines and a growing body of long-term clinical data. This webinar will provide an expert-led analysis of the latest recommendations and clinical findings, with a focus on their practical implications for patient care.
Through focused discussions and real-world case insights, the Faculty led and moderated by Dr Sripal Bangalore (New York University Langone Medical Center, New York, US) will address patient selection, procedural practice, and post-procedural outcomes, highlighting how RDN can be effectively integrated into current care pathways.
This Independent Medical Education programme is supported by Recor Medical
Agenda
Learning Objectives
- Describe guideline recommendations for renal denervation (RDN)
- Recall recent clinical trial data and real-world evidence for RDN
- Apply an evidence-based approach to patient selection for RDN
- Use expert experience to optimise RDN therapy in real-world practice
Target Audience
- Cardiologists
- Interventionalists
- Hypertension Specialists
Faculty Biographies
Sripal Bangalore
Dr Sripal Bangalore is an Interventional Cardiologist and a Professor of Medicine with tenure at New York University School of Medicine.
Ajay J Kirtane
Ajay J Kirtane, is Professor of Medicine at the Columbia University Medical Center (CUMC) and Director of the Cardiac Catheterization Laboratories at NewYork-Presbyterian (NYP) Hospital / CUMC. Dr.
Luke Laffin
Dr Luke Laffin is a physician in the Preventive Cardiology & Rehabilitation Section in the Robert and Suzanne Tomsich Department of Cardiovascular Medicine, Sydell and Arnold Miller Family Heart & Vascular Institute.
Behnam Tehrani
Dr Behnam Tehrani is a System Associate Director for Interventional Cardiology, Executive Director of the Cardiac Catheterization Laboratories for Inova and Co-Director of Complex Coronary Therapeutic Program.